Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,241.34
(
0.10%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
92.44
(
-4.69%
)
Bitcoin
74,885.15
(
-1.27%
)
News Focus
News Focus
Post# of 827881
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Galzus Research

Send PM Follow Ignore
Followers 1
Posts 431
Boards Moderated 0
Alias Born 12/14/2024

Galzus Research

Re: kabunushi post# 771247

Thursday, 06/12/2025 7:28:51 AM

Thursday, June 12, 2025 7:28:51 AM

Post# of 827881
Considering the rumor of approval sent the stock above 0.40, it seems reasonable to conclude that the risk of rejection is not fully priced in.

At the same time, NWBO sits at a $375 million market cap, 50% of Iovance, generating $50 million in revenue per quarter. So on the basis of multiples of sales, NWBO is currently priced in at a level where execution is expected.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News